We are so happy to have attracted the most relevant late breaking trials ever!!!! ERA - European Renal Association #ERA24

Looking forward to meeting some #SoMe friends who have been instrumental in spreading #Nephrology #MedEd to younger generations in the language and format they prefer. #ERA24

#ERA24 Newer options for de-sensitisation #transplant #nephtwitter #Nephpearls 🌟 Promising results with imlifidase even at 3 years 🌟Tocilizumab being evaluated in TETRA study 👇👇

Behind the scenes of the hardworking ERA - European Renal Association SoMe team 🎥 #ERA24 José Silvano

Want to win some ERA swag? Complete a row or column of the bingo card and post your evidence in a thread to be in with a chance to win a limited edition bag. #ERA24

HOW TO TURN YOUR DIALYSIS UNIT GREEN 🥦, by Maria Pippias, Bristol (UK) Excellent talk on environmental changes and its renal outcomes: a 🧵

Feeling the FLOW #ERA24 🇸🇪

Ladies and gentlemen, your #ERA24 (on-site) Social Media team 👏

2/ When should we think of non-HLA antibodies? Reindl-Schwaighofer R 👉Causes of graft loss (50% death, TCMR, AMR, medical): nonHLA-equal contribution 🚨 👉Solutions: better matching, genome wide🧬 👉Tolerance induction + CAR-T technology: 🔜? #ERA24

Want to read some threads on the FLOW results from #ERA24 Evolving landscape x.com/erakidney/stat… Flow design x.com/erakidney/stat… Primary Efficacy Results x.com/erakidney/stat… CV outcomes x.com/erakidney/stat… Safety outcomes x.com/erakidney/stat… Practical

💢 Survival, Water and Fat In Nature and Humans By Prof Richard J Johnson Tweets by Sourabh Sharma Sourabh Sharma MD DNB FASN FISN Social Media Team #ERA24

🧵1/ Artificial Intelligence is trending in #ERA24!🔥 If you want to discover all its different applications, just browse the Abstract 📕! #ANN

📡Telemedicine in nephrology: potential to transform clinical care 🗣️Masaomi Nangaku 👉Improve access to older-person- integrate care 👉Equal patient-reported experience 👉Barriers? like drawing: AI + non-invasive tech such as tear creatinine/gas estimated uremia 🤯 #ERA24

🎯✅Felzartamab in antibody mediated kidney transplant rejection-Late breaking in ERA - European Renal Association 🧐What’s this 💊—CD 38 antibody 🫡Significant resolution of AMR activity after Felzartamab 🎯Is it a new promising drug in AMR 🤨 🗣️by Dr Katharina #ERA24

Felzartamab is safe and could be a potential therapy for ABMR #ERA24

The fourth presentation in #ERA24 LBCT1 session is a very passionate one on 🥁Autoantibodies Targeting Nephrin in Podocytopathies 🥁By Tobias B. Huber Tobias B. Huber International Society of Glomerular Disease Another NEJM worthy trial

Simultaneous publication in JASN_News during Efficacy and safety of avenciguat in diabetic and non-diabetic kidney disease: Pooled analysis from two Phase II randomized controlled clinical trials ✍️By Hiddo Heerspink 🎨Simultaneous visual abstract publication (by

Honored to be ERA - European Renal Association President! Looking FW to advancing care for PeopleWithCKD through innovation, networking, science, inclusiveness. 🙏🏼 to work with council, staff, YNP of ERA NationalSocieties, ERA Registry, WERA, WG, FERA & all ERA - European Renal Association bodies. Let’s boost nephrology!!

Amazing job from our Nephrology Team - Unidade Local de Santo António at #ERA24 ERA - European Renal Association 🇸🇪 Sociedade Portuguesa de Nefrologia Beatriz Braga, Sandra Pereira, Joana Freitas, João Bessa, Ana Castro, Ana Cunha , Joana Tavares , Jorge Malheiro, La Salete Martins 👏

⚠️ ALERTA NefroQuiz de Junho Já estava prometido o novo desafio, pelo que, aqui está ele. Um novo NefroQuiz lançado pelo Grupo de Trabalho de Histomorfologia Renal.